Figure 1.

Immune scores were significantly correlated with clinicopathological parameters and OS. (A and B) Represented the associations of T stage with immune and stromal scores, cases with T stage ≥ 2 were associated with higher immune score rather than stromal score. (C and D) Showed there were no relationship between tumor stage and immune or stromal scores. (E and F) Indicated immune scores were increased with escalation of nuclear grade, but no such trend was observed in stromal scores. From (G-N), correlations of top 4 mutated genes of TCGA with immune and stromal scores were presented. Except for BAP1, immune scores were not correlated with mutations of VHL, PBRM1 and SETD2, while stromal scores were not statistically associated with all four genes. We further analyzed the correlations of immune and stromal scores with OS. (O and P) Showed Kaplan-Meier survival curves of immune and stromal scores for OS.